A new chapter for Christie Innomed: Dr. Michel Vachon and Nicolas Vachon become co-owners of the group with support from the BDC

Christie Innomed Inc., a leader in medical imaging and health technologies, announces that Dr. Michel Vachon and Nicolas Vachon have acquired all the shares of Group Christie and its subsidiaries.

This transaction, carried out with the support of the Business Development Bank of Canada (BDC), consolidates the company’s governance and strengthens its ability to pursue its long-term growth and innovation strategy.

“This acquisition represents a turning point for our organization. By consolidating the ownership of the group, we gain agility and strategic consistency. With BDC’s support, we have solid leverage to invest in our growth, innovate, and create sustainable value for our employees, customers, and partners,” explain Dr. Michel Vachon and Nicolas Vachon, co-owners of Group Christie.

Founded in 1954 by Robert L. Vachon, Christie Innomed remains committed to innovation and quality of care. With over 70 years of expertise and a network of highly qualified specialists across North America, the company supports healthcare systems in their transformation and continuous improvement of their practices.

Under the leadership of Nicolas Vachon, appointed president and CEO in January 2025 and representing the third generation of the family, Christie Innomed draws on its partners to offer high-performance, sustainable solutions tailored to the needs of the North American market. This acquisition also illustrates the management’s commitment to continuing the company’s transformation while remaining true to its founding values: authenticity, innovation, collaboration, and service excellence.

“With its medical imaging and information management solutions, Christie Innomed brings an essential contribution to a sector undergoing rapid modernization. Supporting SME owners in their growth opportunities, such as business transfers, is fully in line with our purpose as a development bank,” said Mouhamad Mrad, Vice President, Corporate Financing, BDC.

About Christie Innomed
Founded in 1954, Christie Innomed develops, distributes, integrates, and supports innovative medical imaging and medical information management equipment that improves the performance of healthcare institutions. Christie Innomed is a leader in Medical Imaging Equipment Solutions, Service Solutions & Multi-Vendor Services (MVS), and Health IT Solutions, with over 200 dedicated specialists serving more than 2,500 hospitals and clinics across Canada and the United States. Through its commitment to innovation and service, Christie Innomed contributes every day to making healthcare more accessible, more efficient, and more human. To learn more about Christie Innomed, visit www.christieinnomed.com or connect with us on LinkedIn.